The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney d...
The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs' reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previous pre-clinical studies, we found hypoxic preconditioning (HPC) enhance...
Alternative Titles
Full title
The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e3f87e4acdf64951aa98a88b3a081f2b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e3f87e4acdf64951aa98a88b3a081f2b
Other Identifiers
ISSN
1757-6512
E-ISSN
1757-6512
DOI
10.1186/s13287-024-03778-1
